Arrowpoint Investment Partners’s Xylem XYL Stock Holding History

Arrowpoint Investment Partners’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,121	Closed	-$134K	–	893
2025 Q1	$134K	Buy	+1,121	New	+$139K	0.02%	796

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowpoint Investment Partners's XYL Position: Q2 2025 in Review

Arrowpoint Investment Partners sold out of Xylem (XYL) in Q2 2025, closing a stake of 1,121 shares — an estimated $134K sold.

Arrowpoint Investment Partners first reported a position in XYL in Q1 2025 and held it in 1 quarter. The position peaked at $134K in Q1 2025. 1,063 funds tracked by Wall St. Rank hold XYL as of Q2 2025.

Arrowpoint Investment Partners reported no remaining Xylem position as of Q2 2025 after selling out during the quarter.
Arrowpoint Investment Partners sold 1,121 Xylem shares in Q2 2025, an estimated $134K.
Arrowpoint Investment Partners first reported a position in Xylem in Q1 2025 and held it in 1 quarter.
Arrowpoint Investment Partners's Xylem position peaked at $134K in Q1 2025.
1,063 funds tracked by Wall St. Rank held Xylem as of Q2 2025.

Based on Arrowpoint Investment Partners's 13F filing for Q2 2025, filed 13 Aug 2025.